Showing results (91-100 of 228) with videos related to

Sort By:
Pageof 23
Cancer Chemotherapy and Pharmacology|March 19, 2009
A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancerOlivier Rixe, Sandra X Franco, Denise A Yardley, et al.
Magnetic Resonance Imaging|July 6, 2020
Should abbreviated breast MRI be compliant with American College of Radiology requirements for MRI accreditation?Marion E Scoggins, Banu K Arun, Rosalind P Candelaria, et al.
Cancer|June 22, 2021
Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genesSukh Makhnoon, Grace Tran, Brooke Levin, et al.
JCO Clinical Cancer Informatics|February 12, 2024
LFSPROShiny: An Interactive R/Shiny App for Prediction and Visualization of Cancer Risks in Families With Deleterious Germline <i>TP53</i> MutationsNam H Nguyen, Elissa B Dodd-Eaton, Gang Peng, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2023
LFSPROShiny: an interactive R/Shiny app for prediction and visualization of cancer risks in families with deleterious germline <i>TP53</i> mutationsNam H Nguyen, Elissa B Dodd-Eaton, Gang Peng, et al.
Annals of Cardiac Anaesthesia|January 25, 2022
Clinical outcomes of del nido cardioplegia and st thomas blood cardioplegia in neonatal congenital heart surgerySameer Mohammed, Sabarinath Menon, Shrinivas V Gadhinglajkar, et al.
Neurology India|September 9, 2022
Mechanical Thrombectomy in Acute Ischemic Stroke: Angiographic Predictors of OutcomeJayadevan E Rajan, Santhosh K Kannath, Sekar Sabarish, et al.
Frontiers in Genetics|May 21, 2016
Evaluation of BRCAPRO Risk Assessment Model in Patients with Ductal Carcinoma In situ Who Underwent Clinical BRCA Genetic TestingNisreen Elsayegh, Angelica M Gutierrez Barrera, Kimberly I Muse, et al.
Cancer Medicine|May 8, 2018
Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancerNisreen Elsayegh, Rachel D Webster, Angelica M Gutierrez Barrera, et al.
Molecular Cancer Therapeutics|November 4, 2010
Silencing kinase-interacting stathmin gene enhances erlotinib sensitivity by inhibiting Ser¹⁰ p27 phosphorylation in epidermal growth factor receptor-expressing breast cancerDongwei Zhang, Ana M Tari, Ugur Akar, et al.
Pageof 23